This announcement is a separate document:
凯普生物：广东信达律师事务所关于公司2021年股票期权激励计划相关事项的法律意见书
Guangdong Hybribio Biotech: Legal Opinion of Guangdong Xinda Law Firm on Matters Related to the Company's 2021 Stock Option Incentive Plan
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.